A month after Johnson & Johnson was slapped with a staggering $4.69 billion verdict in a case brought by 22 women who claimed the company’s talcum powder products were contaminated with asbestos and contributed to their cancer diagnosis, J&J faces another trial linking its talc to cancer.
Carolyn Weirick, 58, said she used Johnson’s Baby Powder and Shower to Shower religiously for the past four decades. When she was diagnosed with mesothelioma – a rare but deadly form of cancer linked to asbestos exposure – she turned one of her baby powder bottles over to researchers and discovered it was laced with more than 6 million asbestos fibers. She filed her lawsuit in April 2017 claiming her use of J&J talcum powder products made her sick. J&J’s talc supplier, Imerys Talc America, is also named in the suit.
Weirick’s attorneys argued that Johnson & Johnson knew its products contained asbestos because their own researchers as well as consultants they hired tested the talc and found it was contaminated. Yet, the company continued to sell the products, promoting them as safe enough for babies. Consumers were never warned of the risks of asbestos exposure.
J&J has been battling numerous lawsuits in recent years over claims that its talcum powder caused ovarian cancer and mesothelioma. The company is still reeling from the $4.69 billion verdict last month over ovarian cancer claims. In May, Johnson & Johnson was hit with a $26 million verdict after a jury found the company’s talcum powders caused a man to develop mesothelioma.